banner
home azienda prodotti anatomia contatti
integratori
ombra_sx
red_line
down
icon
More info  
Vitreous floaters or “flying flies” are a progressively diffuse clinical problem.
Ageing, myopia, dietary and digestive changes, unbalanced diets, atmospheric and luminous polluting agents, and eye operations are all factors which contribute to the development of this problem. It is important to target intervention at improving the metabolism and re-establishing the physiological make-up of the structure of the vitreous humour (water, mineral salts, amino acids, and vitamins) in order to minimize this irritating problem.
 
down
down
icon
Download  

Info in Vista
LE MIODESOPSIE

icon_pdf
Download the file (348 Kb)
 
down
down
icon_biblio
Bibliografia

1. Sebag J. Age-related changes in human vitreous
structure. Graefe’s Arch Clin Exp Ophthalmol 1987;
225(2):89-93.

2. Ueno N, Sebag J, Hirokawa H, Chakrabarti B. Effects
of visible-light irradiation on vitreous structure in
the presence of a photosensitizer. Exp Eye Res 1987
Jun;44(6):863-870.

3. van Overdam KA, Bettink-Remeijer MW, Mulder
PG, van Meurs JC.
Symptoms predictive for the later
development of retinal breaks. Arch Ophthalmol
2001 Oct;119(10):1483-1486.

4. Kakehashi A, Inoda S, Shimizu Y, Makino S, Shimizu
H.
Predictive value of floaters in the diagnosis of
posterior vitreous detachment. Am J Ophthalmol
1998 Jan;125(1):113-115.

5. Weber Krause B, Eckardt C. Incidence of posterior
vitreous detachment in the elderly. Ophtalmologie
1996 Dec;93(6):660-665.

6. Shepens CL. Fundus changes caused by alteration
of vitreous boby. Am J Ophthal 1995;39;631-633.

7. Plantner JM, et al. Matrix metalloproteinases and
metalloproteinase inhibitors in human interphotoreceptor
matrix and vitreous. Current Eye Research
1998;17:132-140.

8. Sethi C, Bayley T, Luthert P, et al. Matrix metalloproteinase biology applied to vitreoretinal disorders.
Br J Ophthalmol 2000;84:654-666.

9. Alexander J. Growth factor and cytokine modulation
of trabecular meshwork matrix metalloproteinase
and TIMP expression. Curr Eye Res 1998;17:276-285.

10. Plantner J. Membrane type-1 matrix metalloproteinase
in human ocular tissues. Curr Eye Res 1997;
16:925-929.

11. Blumenthal M. Asian ginseng: potential therapeutic
uses Adv Nurse Pract 2001 Feb;9(2):26-28, 33.

12. Miura T, Tatara M, Nakamura K, Suzuki I. Effect of
guarana on exercise in normal and epinephrine-induced
glycogenolytic mice. Biol Pharm Bull 1998 Jun;
21(6):646-648.

13. Espinola EB, Dias RF, Mattei R, Carlini EA. Pharmacological
activity of Guarana (Paullinia cupana Mart.)
in laboratory animals. J Ethnopharmacol 1997 Feb;
55(3):223-229.

14. Pessotto P, Valeri P, Arrigoni-Martelli E. The presence
of L-carnitine in ocular tissues of the rabbit. J
Ocul Pharmacol 1994 Winter;10(4):643-651.

15. Levkovitch-Verbin H, Martin KR, Quigley HA,
Baumrind LA, Pease ME, Valenta D.
Measurement of
amino acid levels in the vitreous humor of rats after
chronic intraocular pressure elevation or optic nerve
transection. J Glaucoma. 2002 Oct;11(5):396-405.

16. Durham DG. Distribution of free amino acids in
human intraocular fluids. Trans Am Ophthalmol Soc
1970;68:462-500.

17. Remer T. Influence of diet on acid-base balance.
Semin Dial 2000 Jul-Aug;13(4):221-226.

18. Ainley RG, Phillips CI, Gibbs A, Acheson RR, Watson-
Williams EJ, Bottomley AC.
Aqueous humour vitamin
B12 and intramuscular cobalamins. Br J
Ophthalmol. 1969 Dec;53(12):854-857.

19. Davidson GE, Weir DG, Scott JM. The metabolic
consequences of vitamin B-12/methionine deficiency
in rats. Biochim Biophys Acta 1975 Jun 12;392(2):
207-215.

 

 
down
 
oxigen
Composition
L-Lisine 400 mg
L-Arginine 250 mg
L-Carnitine 70 mg
Magnesium 300 mg
Potassium 200 mg
Vitamin B1 1,4 mg
Vitamin B2 1,6 mg
Vitamin B6 2 mg
Vitamin B12 1 mcg
Pantothenic Acid 6 mg
Vitamin PP 18 mg
Guaranà dry extract 25 mg
Ginseng dry extract 200 mg
 
Description

FIELD OF USE
OXIGEN® is recommended when there is an increased need for or reduced dietary intake of its component nutrients. It is particularly indicated for strain and asthenia.
In the vitreous, it could be useful to restore the perturbed physiological equilibrium.

DESCRIPTION
These effervescent tablets are a preparation comprising a rational combination of natural substances, useful when symptoms of strain and asthenia are exhibited due to insufficient nutritional intake.
The amino acids Lysine, Arginine and Carnitine help to improve the protein synthesis mechanism, with a direct effect on cellular energy production.
In particular, Carnitine facilitates energy production by conveying fatty acids to the sites where they are used.
The amino acids also have a fundamental role in the correct formation of collagen also in the vitreous humour.
The B-group Vitamins, especially Vitamins B2 and B6, are necessary for the production of energy from carbohydrates.
Vitamin B6, in particular, represents the coenzyme of energy metabolism.
Vitamin B12 is involved in cellular synthesis, and a deficiency of it can cause asthenia.
Magnesium helps increase protein synthesis and muscular contractility. When deficient, performance may diminish during physical exercise, with an increased occurrence of muscle cramps.
Potassium has a fundamental role in protein synthesis, in maintaining the body’s water balance, in muscle contraction and in nerve transmission. It also activates a number of enzymes, especially those involved in energy production. A Potassium deficiency causes asthenia and lowering of arterial blood pressure. The extract of Guarana is a natural stimulant and long-term energizer.
Guarana extract is considered to enhance energy production through promoting the
metabolism of fats for energy purposes (thermogenesis).
The Ginseng extract helps the body adapt to stressful events, of both internal and external origins, thus enabling it to be used as an “adaptogen”.

 
Product Use

INSTRUCTIONS FOR USE
Recommended consumption: one tablet each morning, dissolved in a glass of water (200 ml).

DO NOT USE
If there is known hypersensitivity to one of the product’s ingredients.

PRECAUTIONS AND WARNINGS
Pregnant women or nursing mothers are advised not to use the product.
Do not exceed the recommended doses.
Does not contain gluten.
Keep the preparation out of the reach of children.

PACK
Box: 2 tubes containing 10 EFFERVESCENT TABLETS.

 

 

 
 
flaguk end